Octreotide - NDC Database (Page 3)
25021-463 Jun 15, 2023
Octreotide Acetate 50 ug/ml Intravenous; Subcutaneous Injection, Solution by Sagent Pharmaceuticals
Octreotide Acetate 50 ug/ml Intravenous; Subcutaneous Injection, Solution by Sagent Pharmaceuticals
25021-464 Jun 15, 2023
Octreotide Acetate 100 ug/ml Intravenous; Subcutaneous Injection, Solution by Sagent Pharmaceuticals
Octreotide Acetate 100 ug/ml Intravenous; Subcutaneous Injection, Solution by Sagent Pharmaceuticals
25021-465 Jun 15, 2023
Octreotide Acetate 500 ug/ml Intravenous; Subcutaneous Injection, Solution by Sagent Pharmaceuticals
Octreotide Acetate 500 ug/ml Intravenous; Subcutaneous Injection, Solution by Sagent Pharmaceuticals
25021-466 Jun 15, 2023
Octreotide Acetate 200 ug/ml Intravenous; Subcutaneous Injection, Solution by Sagent Pharmaceuticals
Octreotide Acetate 200 ug/ml Intravenous; Subcutaneous Injection, Solution by Sagent Pharmaceuticals
25021-467 Jun 15, 2023
Octreotide Acetate 1000 ug/ml Intravenous; Subcutaneous Injection, Solution by Sagent Pharmaceuticals
Octreotide Acetate 1000 ug/ml Intravenous; Subcutaneous Injection, Solution by Sagent Pharmaceuticals
52958-046 May 02, 2024
Octreotide Acetate 100 ug/ml Intravenous; Subcutaneous Injection, Solution by Hainan Shuangcheng Pharmaceuticals Co., Ltd.
Octreotide Acetate 100 ug/ml Intravenous; Subcutaneous Injection, Solution by Hainan Shuangcheng Pharmaceuticals Co., Ltd.
55390-160 Apr 04, 2005
Octreotide Acetate 50 ug/ml Intravenous; Subcutaneous Injection, Solution by Bedford Laboratories
Octreotide Acetate 50 ug/ml Intravenous; Subcutaneous Injection, Solution by Bedford Laboratories
55390-161 Apr 04, 2005
Octreotide Acetate 100 ug/ml Intravenous; Subcutaneous Injection, Solution by Bedford Laboratories
Octreotide Acetate 100 ug/ml Intravenous; Subcutaneous Injection, Solution by Bedford Laboratories
55390-162 Apr 04, 2005
Octreotide Acetate 500 ug/ml Intravenous; Subcutaneous Injection, Solution by Bedford Laboratories
Octreotide Acetate 500 ug/ml Intravenous; Subcutaneous Injection, Solution by Bedford Laboratories
55390-163 Apr 08, 2005
Octreotide Acetate 200 ug/ml Intravenous; Subcutaneous Injection, Solution by Bedford Laboratories
Octreotide Acetate 200 ug/ml Intravenous; Subcutaneous Injection, Solution by Bedford Laboratories
55390-164 Apr 08, 2005
Octreotide Acetate 1000 ug/ml Intravenous; Subcutaneous Injection, Solution by Bedford Laboratories
Octreotide Acetate 1000 ug/ml Intravenous; Subcutaneous Injection, Solution by Bedford Laboratories
55648-632 May 11, 2011
Octreotide Acetate 1000 ug/ml Intravenous; Subcutaneous Injection by Wockhardt Limited
Octreotide Acetate 1000 ug/ml Intravenous; Subcutaneous Injection by Wockhardt Limited
55648-633 May 11, 2011
Octreotide Acetate 100 ug/ml Intravenous; Subcutaneous Injection by Wockhardt Limited
Octreotide Acetate 100 ug/ml Intravenous; Subcutaneous Injection by Wockhardt Limited
55648-634 May 11, 2011
Octreotide Acetate 200 ug/ml Intravenous; Subcutaneous Injection by Wockhardt Limited
Octreotide Acetate 200 ug/ml Intravenous; Subcutaneous Injection by Wockhardt Limited
55648-635 May 11, 2011
Octreotide Acetate 500 ug/ml Intravenous; Subcutaneous Injection by Wockhardt Limited
Octreotide Acetate 500 ug/ml Intravenous; Subcutaneous Injection by Wockhardt Limited
55648-636 May 11, 2011
Octreotide Acetate 50 ug/ml Intravenous; Subcutaneous Injection by Wockhardt Limited
Octreotide Acetate 50 ug/ml Intravenous; Subcutaneous Injection by Wockhardt Limited
62756-093 Aug 31, 2012
Octreotide Acetate 50 ug/ml Intravenous; Subcutaneous Injection, Solution by Sun Pharmaceutical Industries Limited
Octreotide Acetate 50 ug/ml Intravenous; Subcutaneous Injection, Solution by Sun Pharmaceutical Industries Limited
62756-094 Aug 31, 2012
Octreotide Acetate 100 ug/ml Intravenous; Subcutaneous Injection, Solution by Sun Pharmaceutical Industries Limited
Octreotide Acetate 100 ug/ml Intravenous; Subcutaneous Injection, Solution by Sun Pharmaceutical Industries Limited
62756-095 Aug 31, 2012
Octreotide Acetate 500 ug/ml Intravenous; Subcutaneous Injection, Solution by Sun Pharmaceutical Industries Limited
Octreotide Acetate 500 ug/ml Intravenous; Subcutaneous Injection, Solution by Sun Pharmaceutical Industries Limited
62756-348 Aug 14, 2007
Octreotide Acetate 50 ug/ml Intravenous; Subcutaneous Injection, Solution by Sun Pharmaceutical Industries Limited
Octreotide Acetate 50 ug/ml Intravenous; Subcutaneous Injection, Solution by Sun Pharmaceutical Industries Limited
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.